CAERUS CAPITAL AS

CAERUS CAPITAL AS is registered as a limited company in Oslo, Oslo with organisation number 984276141. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2001. Registered share capital is NOK 50,000, divided into 1 shares. The company's stated purpose is: “Produktutvikling i farmasøytisk industri, konsulentvirksomhet, investeringsvirksomhet samt deltakelse i andre foretak.”. The most recent filed accounts, for the 2025 financial year, show NOK 1.7m in revenue and NOK 1.6m in operating profit.

Key figures · 2025

Revenue

NOK 1.7m

Operating profit

NOK 1.6m

Equity

NOK 10.3m

Est. value

NOK 11.6m

Financial health · 2025

Liquidity

32.05

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

97.0%

Very good

Equity as a share of total capital

Who owns CAERUS CAPITAL AS?

TORGEIR VAAGE

100.0%

CAERUS CAPITAL AS

NOK 1.7m rev. · NOK 1.6m profit

CAERUS CAPITAL AS has 1 registered shareholder:

• TORGEIR VAAGE 100.0%

All shareholders and roles →

Which companies does CAERUS CAPITAL AS own?

CAERUS CAPITAL AS holds stakes in 4 companies:

• PROPHYLIX PHARMA HOLDING AS 1.0%
• PROPHYLIX PHARMA HOLDING AS 0.2%
• PARETO BANK ASA 0.0%
• ALGINOR ASA 0.0%

See the full ownership structure →

Frequently asked questions about CAERUS CAPITAL AS

Who owns CAERUS CAPITAL AS?

TORGEIR VAAGE is the largest registered owner, with 100.0%.

What is the revenue of CAERUS CAPITAL AS?

CAERUS CAPITAL AS had revenue of NOK 1.7m in 2025.

Who is the general manager of CAERUS CAPITAL AS?

Torgeir Vaage is registered as general manager of CAERUS CAPITAL AS.

Where is CAERUS CAPITAL AS based?

CAERUS CAPITAL AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.